BOSTON (MarketWatch) -- Shares of Dendreon Corp. /quotes/zigman/83175/quotes/nls/dndn DNDN -18.04% plunged 18% to $12.12 on Monday after it issued a weaker-than-expected quarterly sales report for its prostate cancer therapy Provenge. Dendreon shares have been on a roll since early January, when the stock soared almost 50% on stronger-than-expected sales for the therapy. Despite Monday's plunge, Dendreon's shares are still up nearly 60% for the year.
- Forums
- ASX - By Stock
- IMM
- follow the right path for success
follow the right path for success, page-8
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.0¢ |
Change
-0.005(1.45%) |
Mkt cap ! $493.8M |
Open | High | Low | Value | Volume |
34.0¢ | 34.0¢ | 32.5¢ | $1.317M | 3.935M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 73996 | 33.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 836970 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 67679 | 0.325 |
11 | 193888 | 0.320 |
1 | 25000 | 0.315 |
2 | 35400 | 0.310 |
5 | 103336 | 0.305 |
Price($) | Vol. | No. |
---|---|---|
0.340 | 674262 | 1 |
0.345 | 179754 | 4 |
0.350 | 527571 | 5 |
0.355 | 30000 | 1 |
0.360 | 51000 | 2 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |